John Cullinan

John Cullinan, BAFS, MA, MSc, PhD, is a Senior Lecturer in Economics at the JE Cairnes School of Business and Economics at National University of Ireland Galway, Galway, Ireland; the Vice Dean for Research in the College of Business, Public Policy and Law and Associate Head of Research in the School of Business and Economics; member of NUI Galway's Research Committee, Quality and Innovation Committee and GIS Centre Committee; and the Policy Section Editor of The Economic and Social Review.

Research interests include the application of economic techniques to the areas of health, disability, higher education and natural resources.

Awards

• 2016 - President's Award for Excellence in Teaching
• 2017 - President's Award for Excellence in Research

EUROMENE

Dr. Cullinan is a member of the Socio-economics Working Group of EUROMENE, a European Union COST Action CA15111 not-for-profit research organization committed to tackling the cause and treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Notable studies

• 2020, The Development of a Consistent Europe-Wide Approach to Investigating the Economic Impact of Myalgic Encephalomyelitis (ME/CFS): A Report from the European Network on ME/CFS (EUROMENE) - (Full text)

See also

• EUROMENE

myalgic encephalomyelitis (M.E.) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.